| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3943284 | Gynecologic Oncology | 2009 | 5 Pages |
Abstract
FIGO stage, residual tumor, and primary chemotherapy are significant prognostic factors for ovarian cancer. Hospital volume is associated with residual tumor. The results favor performance of ovarian cancer surgery in hospitals with higher operative volumes.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Salla Kumpulainen, Risto Sankila, Arto Leminen, Tapio Kuoppala, Marja Komulainen, Ulla Puistola, Saija Hurme, Heikki Hiekkanen, Juha Mäkinen, Seija Grénman,